Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Endocrinol. 2018 Oct 16;239(2):253–265. doi: 10.1530/JOE-18-0382

Table 3.

mRNA expression levels in control and IUGR fetal sheep LV and RV aged ~134 dGA.

Relative Expression Levels Interaction Main Effects
RV LV Treatment Ventricle
Control
(n=3)
IUGR
(n=7)
Control
(n=7)
IUGR
(n=13)
P-value P-value P-value
Reference genes
  RPL32 0.99±0.22 0.93±0.18 1.00±0.04 0.98±0.25 ns ns ns
  RPL37A 1.01±0.31 1.03±0.17 1.00±0.16 1.08±0.27 ns ns ns
  MLF2 1.03±0.15 1.05±0.24 1.00±0.18 0.92±0.28 ns ns ns
Cyclins
  Cyclin A2 1.28±0.55 0.67±0.23 1.00±0.51 0.57±0.23 ns 0.0014 ns
  Cyclin B1 1.98±1.18 0.74±0.23 1.00±0.44 0.67±0.33 0.0306
  Cyclin B2 1.61±0.88 0.74±0.26 1.00±0.27 0.72±0.23 ns 0.0006 0.0381
  Cyclin D1 1.15±0.16 1.16±0.22 1.00±0.23 1.13±0.34 ns ns ns
  Cyclin D2 1.87±0.24 1.50±0.30 1.00±0.20 1.02±0.16 0.043
  Cyclin E2 1.03±0.27 0.94±0.15 1.00±0.21 0.82±0.25 ns ns ns
Cyclin dependent kinases
  CDK1 1.37±0.57 0.86±0.29 1.00±0.35 0.62±0.37 ns 0.009 ns
  CDK4 1.02±0.13 1.10±0.21 1.00±0.15 0.94±0.19 ns ns ns
  CDK6 1.40±0.07 1.14±0.16 1.00±0.14 0.97±0.09 0.0345
Cyclin dependent kinase inhibitors
  CDKN2C (p18) 1.12±0.19 1.06±0.19 1.00±0.18 0.80±0.22 ns ns 0.0348
  CDKN1A (p21) 0.49±0.15 0.67±0.18 1.00±0.42 0.91±0.26 ns ns 0.0041
  CDKN1B (p27) 0.92±0.03 1.23±0.35 1.00±0.11 0.99±0.25 ns ns ns
Cell cycle effectors and checkpoint genes
  MCM6 0.97±0.21 0.99±0.15 1.00±0.20 0.87±0.19 ns ns ns
  PLK1 1.47±0.99 0.78±0.28 1.00±0.78 0.70±0.30 ns 0.0299 ns
  CDC20 1.26±0.56 0.84±0.22 1.00±0.34 0.74±0.22 ns 0.0101 ns
  MAD2 1.23±0.40 0.87±0.21 1.00±0.26 0.70±0.32 ns 0.0134 ns
  BUB1 2.20±1.49 0.48±0.51 1.00±0.69 0.38±0.48 ns 0.0004 0.0303
  ESPL1 1.00±0.56 0.70±0.30 1.00±0.63 0.54±0.18 ns 0.0251 ns
  CHK1 1.09±0.21 1.10±0.31 1.00±0.25 0.83±0.38 ns ns ns
  DBF4 1.50±0.47 0.79±0.14 1.00±0.36 0.83±0.29 0.0398
  YWHAZ 1.34±0.19 1.13±0.19 1.00±0.14 0.93±0.19 ns ns 0.0015
Transcription factors
  TFDP1 0.96±0.10 0.94±0.14 1.00±0.09 0.94±0.16 ns ns ns
  Meis1 1.21±0.11 1.04±0.32 1.00±0.19 1.07±0.28 ns ns ns

Groups compared by 2-way ANOVA.

*

Different from ipsilateral control by Holm-Sidak test (P<0.05). Data are shown as mean±standard deviation.